Literature DB >> 9120180

Ischemic burden in silent and painful myocardial ischemia: a quantitative exercise sestamibi tomographic study.

C Marcassa1, M Galli, C Baroffio, R Campini, P Giannuzzi.   

Abstract

OBJECTIVES: We sought to determine whether the amount of myocardial ischemic burden differs in patients with painful or silent myocardial hypoperfusion during exercise testing.
BACKGROUND: Whether a lack of symptoms during ischemia reflects an alteration in pain perception or less myocardium in jeopardy remains a controversial issue.
METHODS: We studied 300 consecutive patients with a well established history of ischemic heart disease and reversible hypoperfusion on exercise sestamibi tomography. Rest and stress sestamibi defects were quantitatively assessed and indexes of exercise left ventricular dilation derived.
RESULTS: Painful and silent reversible ischemia was observed in 97 (32%) and 203 (68%) patients, respectively. Patients with painful ischemia had lower values for work load, exercise time and peak rate-pressure product (p < 0.01) and more frequently showed significant ST segment depression during exercise than did patients with silent ischemia (69% vs. 40%, p < 0.001). On sestamibi tomography, patients with painful ischemia had more reversible hypoperfusion than did patients with silent ischemia (mean +/- SD 16 +/- 10% vs. 11 +/- 7%, p < 0.001), despite a comparable extent of stress hypoperfusion (22 +/- 12% vs. 22 +/- 13%); they also had a higher endocardial dilation index (1.32 +/- 0.32 vs. 1.10 +/- 0.26, p < 0.001). By multivariate logistic analysis, the most powerful correlate of painful ischemia was a history of effort angina; the extent of reversible perfusion defect was the sole independent scintigraphic correlate of painful ischemia.
CONCLUSIONS: To our knowledge, this is the largest study comparing the degree of hypoperfusion and the presence of symptoms during exercise stress testing in a consecutive cohort of patients with ischemic heart disease and reversible hypoperfusion. The results suggest that the ischemic burden is greater in painful than in silent ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120180     DOI: 10.1016/s0735-1097(97)00006-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Electrocardiographic evolution after Q-wave anterior myocardial infarction: correlations between QRS score and changes in left ventricular perfusion and function.

Authors:  C Marcassa; M Galli; A Paino; R Campini; R Giubbini; P Giannuzzi
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

2.  Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography.

Authors:  E Biagini; A F L Schinkel; J J Bax; V Rizzello; R T van Domburg; B J Krenning; M Bountioukos; C Pedone; E C Vourvouri; C Rapezzi; A Branzi; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 3.  Visceral chest pain in unstable angina pectoris and effects of transcutaneous electrical nerve stimulation. (TENS). A review.

Authors:  M Börjesson
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

4.  Transient left ventricular dilation at quantitative stress-rest sestamibi tomography: clinical, electrocardiographic, and angiographic correlates.

Authors:  C Marcassa; M Galli; C Baroffio; R Campini; P Giannuzzi
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

5.  Paucity of anginal symptoms and stress-induced perfusion abnormalities in ischemic cardiomyopathy.

Authors:  Alessia Gimelli; Paolo Marzullo; Patrizia Landi; Antonio L'Abbate; Matteo Bottai; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2008-07-26       Impact factor: 5.952

6.  Psychological and physiological predictors of angina during exercise-induced ischemia in patients with coronary artery disease.

Authors:  Nadine S Bekkouche; Andrew J Wawrzyniak; Kerry S Whittaker; Mark W Ketterer; David S Krantz
Journal:  Psychosom Med       Date:  2013-04-10       Impact factor: 4.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.